News Search Results
Nov 29, 2024, 17:05 ET Cannabis Testing Market to Grow by USD 2.05 Billion (2024-2028), Rising Medical Cannabis Use Boosts Revenue, Report Highlights AI-Driven Market Evolution - Technavio
experiencing significant growth due to increasing demand for medical cannabis and stricter regulatory standards. However, challenges persist for cannabis testing labs, including the use of complex LIMS systems and high testing costs. Medical cannabis patients, such as those undergoing chemotherapy for cancer
More news about: Technavio
Nov 29, 2024, 16:05 ET Cansortium Reports Third Quarter 2024 Results
Florida and we have made no financial commitments which depended on the adult use measure. FLUENT remains committed to the mission of serving the medical cannabis patients of Florida." Mr. Beasley concluded, "Looking ahead, with our primary loan refinancing
More news about: Cansortium Inc.
Nov 29, 2024, 08:00 ET RIV Capital Reports Financial Results for the Third Quarter Ended September 30, 2024
until mid-September. Wholesale revenue of $1.6 million was generated from sales of internally-produced adult-use and medical cannabis products to other adult-use or medical dispensaries in New York, as well as sales of bulk flower to other license
More news about: RIV Capital Inc.
Nov 26, 2024, 07:30 ET Canopy Growth Announces Mr. Luc Mongeau As The Company's Next CEO
throughout this transformative period in Canopy Growth's history." "With some of the best-known brands in the industry, a strong global medical cannabis business, category leading vaporizers from Storz & Bickel, and unique exposure to the high-potential U.S. cannabis market, Canopy Growth is
More news about: Canopy Growth Corporation
Nov 26, 2024, 07:00 ET Aurora Announces Medical Product Advancements from Leading Cannabis Research Facility
NASDAQ | TSX: ACB Canada's Largest Medical Cannabis Company Continues to Offer Greater Choice for Patients EDMONTON, AB,
More news about: Aurora Cannabis Inc.
Nov 26, 2024, 06:00 ET REVOLUTIONIZING CANNABIS EDUCATION: THE PERIODIC TABLE OF CANNABIS MOLECULES
Joseph Friedman, RPh, MBA, a Scientific Advisory Board of Acannability member. Drawing on his extensive experience in the medical cannabis industry, Joseph identified and categorized the most researched molecules, creating a resource that stands out for its depth and accuracy. Existing
More news about: Acannability
Nov 22, 2024, 08:15 ET Trulieve to Open Medical Cannabis Dispensary in Jacksonville, Florida
TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., announced the opening of a new medical cannabis dispensary in Jacksonville, Florida on Saturday, November 23.
More news about: Trulieve Cannabis Corp.
Nov 20, 2024, 09:00 ET Mango Cannabis Announces Strategic Partnership With Leafwell
The partnership will increase patient access and education and allow patients to receive their medical cannabis cards through an expedited and streamlined process. Mango employees will direct qualified patients to Leafwell's platform to connect with state-licensed
More news about: Leafwell
Nov 20, 2024, 07:30 ET Aurora Cannabis Expands Innovative Recreational Product Portfolio
Nov. 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is excited to announce its latest lineup of innovations from Greybeard, San Rafael '71 and Tasty's brands. With a continued
More news about: Aurora Cannabis Inc.
Nov 20, 2024, 07:30 ET Canopy Growth Launches Claybourne Infused Pre-Rolls in Canada
recreational cannabis e-commerce channels and retail locations in select regions in addition to the Spectrum Therapeutics online store for authorized medical cannabis consumers. To keep up with the latest from Claybourne, follow them on
More news about: Canopy Growth Corporation
Nov 19, 2024, 08:00 ET Trulieve to Open Florida Medical Cannabis Dispensaries in Dania Beach and Spring Hill
TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of new medical cannabis dispensaries in Dania Beach and Spring Hill, Florida.
More news about: Trulieve Cannabis Corp.
Nov 19, 2024, 07:00 ET Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results
develop human microbiome-based therapeutics by Biomica, ag-biologicals by Lavie Bio, ag-chemicals by AgPlenus, medical cannabis products by Canonic and castor varieties, for the biofuel and other industries, by Casterra. For more information, please visit:
More news about: Lavie Bio
Nov 14, 2024, 08:15 ET IM Cannabis Reports Third Quarter Financial Results
Nov. 14, 2024 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial results today for the third quarter ended September 30, 2024. All amounts are reported
More news about: IM Cannabis Corp.
Nov 14, 2024, 08:15 ET IM Cannabis Reports Third Quarter Financial Results
Nov. 14, 2024 /CNW/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial results today for the third quarter ended September 30, 2024. All amounts are reported
More news about: IM Cannabis Corp.
Nov 14, 2024, 07:00 ET MediPharm Labs Reports Third Quarter Results
and Beacon Medical Germany GmbH. This acquisition also included Harvest Medical Clinics in Canada which provides medical cannabis patients with Physician consultations for medical cannabis education and prescriptions. Notes:
More news about: MediPharm Labs Corp.
Nov 12, 2024, 17:40 ET IM Cannabis Closes Non-Brokered Private Placement led by Management and Concurrent Debt Settlement
12, 2024 /PRNewswire/ -- IM Cannabis Corp. ("IM Cannabis" or the "Company") (NASDAQ: IMCC) (CSE: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that,
More news about: IM Cannabis Corp.
Nov 12, 2024, 17:40 ET IM Cannabis Closes Non-Brokered Private Placement led by Management and Concurrent Debt Settlement
Nov. 12, 2024 /CNW/ -- IM Cannabis Corp. ("IM Cannabis" or the "Company") (NASDAQ: IMCC) (CSE: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that,
More news about: IM Cannabis Corp.
Nov 12, 2024, 07:00 ET Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials
develop human microbiome-based therapeutics by Biomica, ag-biologicals by Lavie Bio, ag-chemicals by AgPlenus, medical cannabis products by Canonic and castor varieties, for the biofuel and other industries, by Casterra. For more information, please visit:
More news about: Lavie Bio
Nov 11, 2024, 17:12 ET Laboratory Information Management System Market to Grow by USD 1.63 Billion from 2024-2028, Recent Developments Boost Growth, Report with AI-Powered Market Evolution - Technavio
decisions for scientists. Compliant with regulations such as 21 CFR Part 11, these systems ensure data security and integrity. In the realm of medical cannabis, cannabis testing laboratories have adopted LIMS solutions to manage complex workflows, track samples, and analyze data for result reporting and
More news about: Technavio
Nov 11, 2024, 06:15 ET MediPharm Labs Sets Date to Report Third Quarter 2024 Financial Results
This acquisition also included Harvest Medical Clinics in Canada which provides medical cannabis patients with Physician consultations for medical cannabis education and prescriptions. The Company carries out its operations in compliance with all applicable laws
More news about: MediPharm Labs Corp.
Nov 08, 2024, 07:00 ET Canopy Growth Reports Second Quarter Fiscal Year 2025 Financial Results
Storz & Bickel net revenue increased 32% year-over-year in Q2 FY2025 Continued growth across medical cannabis businesses, with net revenue increasing year-over-year by 16% in Canada and 12% in international markets
More news about: Canopy Growth Corporation
Nov 06, 2024, 08:00 ET IM Cannabis to Report Third Quarter 2024 Financial Results on Thursday, November 14th at 9:00am ET
2024 /CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial
More news about: IM Cannabis Corp.
Nov 06, 2024, 08:00 ET IM Cannabis to Report Third Quarter 2024 Financial Results on Thursday, November 14th at 9:00am ET
2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial
More news about: IM Cannabis Corp.
Nov 06, 2024, 07:00 ET Aurora Cannabis Announces Fiscal 2025 Second Quarter Results
million in Q2 2025 vs $32.0 million in the prior year quarter, an increase of 33%. Medical Cannabis:Medical cannabis net revenue1 was $61.3 million, a 41% increase from the prior year quarter, delivering
More news about: Aurora Cannabis Inc.
Oct 29, 2024, 10:00 ET 2024 ECONOMIC IMPACT AWARDS WINNERS DRIVE GROWTH IN GREATER DES MOINES
Economic Impact Award winners are: Bud & Mary's CannabisBud & Mary's is Iowa's first medical cannabis manufacturer and dispensary operator. In 2022, the company recognized that its current capacity wouldn't be able to serve the needs of the growing
More news about: Greater Des Moines Partnership